Due to the stimulation of pathways triggering EMT and cell growth-related intracellular signals by CD24, Nakamura et al. [198] suggested that this molecule plays an important role in metastatic progression and could be a promising therapeutic target in advanced ovarian cancer. The gene discussed is CD24; the disease is ovarian carcinoma.